Bladder cancer is among the more common cancers encountered in the veteran population and use of blue light cystoscopy has improved the detection and treatment of the cancer in the VA population, according to Joseph C. Liao, MD, Associate Professor of Urology at Stanford University in Palo Alto, California, and Chief of Urology at the Palo Alto VA Health System. His VA hospital was among the first in the system to acquire blue light cystoscopy.
“Surgery is all about seeing and doing,” Dr. Liao said, adding that improvement in the ability to visualize tumors allows surgeons to resect them with better margin status.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.